Despite the coronavirus, Johnson &amp; Johnson $JNJ is raising its dividend while many companies are suspending or cutting theirs. The company is also working on a potential COVID-19 vaccine, which is another tailwind.

Learn more about our #StockOfTheWeek - https://t.co/vJc7HeWT9j https://t.co/nKmzVr33XE